Robert Latkany, M.D.
NPI 1487681482 · Ophthalmology Physician · New York, NY
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Robert Latkany, M.D. is a Ophthalmology Physician provider in New York, NY (NPI 1487681482).
Provider details
- NPI number
- 1487681482
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 211508-1 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,928 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Problem Focused Exam of Visual System92012 | 1,171 | $101 |
| Established Patient Complete Exam of Visual System92014 | 538 | $142 |
| Imaging of Optic Nerve92133 | 290 | $39 |
| Exam of Visual Field With Extended Testing92083 | 289 | $72 |
| Exam of the Internal Drainage System of Eye92020 | 233 | $30 |
| New Patient Complete Exam of Visual System92004 | 153 | $167 |
| Closure of Tear Duct Opening Using Plug |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 28 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 243 | 67 |
| Timolol Maleate | 161 | 39 |
| Bimatoprostbrand: Lumigan | 74 | 16 |
| Perfluorohexyloctane/Pfbrand: Miebo | 74 | 25 |
| Tobramycin/Dexamethasonebrand: Tobramycin-Dexamethasone | 69 | 56 |
| Azelastine Hcl | 62 | 26 |
| Brimonidine Tartrate | 58 | 11 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$7,905 across 35 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-26
- Last updated
- 2011-05-24
Frequently asked questions
- What is Robert Latkany's NPI number?
- Robert Latkany's National Provider Identifier (NPI) is 1487681482, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Robert Latkany's specialty?
- Robert Latkany is listed in the NPPES registry with a primary specialty of Ophthalmology Physician (Allopathic & Osteopathic Physicians).
- Where is Robert Latkany located?
- Robert Latkany's practice location on file with NPPES is 150 E 32nd St, New York, NY 10016-6058.
- What is Robert Latkany's phone number?
- The practice phone number listed in the NPPES registry for Robert Latkany is (212) 689-2020.
- Does Robert Latkany accept Medicare?
- Robert Latkany is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Robert Latkany's NPI active?
- Yes — Robert Latkany's NPI (1487681482) is active in the NPPES registry as of the last update on 2011-05-24.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.